Truncated Midkine as a Marker of Diagnosis and Detection of Nodal Metastases in Gastrointestinal Carcinomas

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1998.517
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Diagnosis of Cancer as a Marker

The Primary Care Companion to The Journal of Clinical Psychiatry
2007English

Papillary Thyroid Carcinomas With Cervical Lymph Node Metastases Can Be Stratified Into Clinically Relevant Prognostic Categories Using OncogenicBRAF, the Number of Nodal Metastases, and Extra-Nodal Extension

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2012English

The Serum Level of Midkine, a Heparin-Binding Growth Factor, as a Tumor Marker

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
1997English

Cytokeratin 14 as a Marker of Squamous Differentiation in Transitional Cell Carcinomas.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1997English

Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas

Iranian Journal of Pathology
Forensic MedicinePathology
2020English

Serum Midkine Levels Are Increased in Patients With Various Types of Carcinomas

British Journal of Cancer
Cancer ResearchOncology
2000English

Evaluation of a 3a-Truncated Foot-And-Mouth Disease Virus in Pigs for Its Potential as a Marker Vaccine

Veterinary Research
Veterinary
2014English

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

Clinical medicine. Oncology
2008English

Clinicopathological Differences of Nodal PTCL With TFH Phenotype From Aitl and Ptcl, Nos, and Detection of Prognostic Marker of Nodal PTCL With TFH Phenotype

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy